Connection

Gary Gilkeson to Risk Assessment

Back to Details
This is a "connection" page, showing publications Gary Gilkeson has written about Risk Assessment.
Gary Gilkeson
Connection Strength
0.094
Risk Assessment
  1. New therapies and preventive strategies to treat and minimize damage in lupus. Curr Rheumatol Rep. 2005 Dec; 7(6):457-62.
    View in: PubMed
    Score: 0.042
  2. Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features. Arthritis Rheumatol. 2017 03; 69(3):630-642.
    View in: PubMed
    Score: 0.023
  3. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis. 2016 Jan; 75(1):242-52.
    View in: PubMed
    Score: 0.019
  4. Developmental immunotoxicity of trichloroethylene (TCE): studies in B6C3F1 mice. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006; 41(3):249-71.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.